An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Wagner AD, Grabsch HI, Mauer M, Marreaud S, Caballero C, Thuss-Patience P, Mueller L, Elme A, Moehler MH, Martens U, Kang YK, Rha SY, Cats A, Tokunaga M, Lordick F.Wagner AD, et al. Among authors: kang yk.BMC Cancer. 2019 May 24;19(1):494. doi: 10.1186/s12885-019-5675-4.BMC Cancer. 2019.PMID: 31126258Free PMC article.Clinical Trial.
Lee JH, Lee JH, Ahn JH, Bahng H, Kim TW, Kang YK, Lee KH, Kim JC, Yu CS, Kim JH, Ahn SD, Kim WK, Kim SH, Lee JS.Lee JH, et al. Among authors: kang yk.J Clin Oncol. 2002 Apr 1;20(7):1751-8. doi: 10.1200/JCO.2002.07.037.J Clin Oncol. 2002.PMID: 11919231Clinical Trial.
Ahn JH, Kang YK, Kim TW, Bahng H, Chang HM, Kang WC, Kim WK, Lee JS, Park JS.Ahn JH, et al. Among authors: kang wc, kang yk.Cancer Chemother Pharmacol. 2002 Aug;50(2):104-10. doi: 10.1007/s00280-002-0483-x. Epub 2002 Jun 25.Cancer Chemother Pharmacol. 2002.PMID: 12172973Clinical Trial.
Ahn JH, Kim TW, Lee JH, Min YJ, Kim JG, Kim JC, Yu CS, Kim WK, Kang YK, Lee JS.Ahn JH, et al. Among authors: kang yk.Am J Clin Oncol. 2003 Feb;26(1):98-102. doi: 10.1097/01.COC.0000017089.68491.1F.Am J Clin Oncol. 2003.PMID: 12576934Clinical Trial.
Kim TW, Kang WK, Chang HM, Park JO, Ryoo BY, Ahn JS, Zang DY, Lee KH, Kang YK, Kim SR, Kim HK; Korean Cancer Study Group.Kim TW, et al. Among authors: kang wk, kang yk.Acta Oncol. 2005;44(3):230-5. doi: 10.1080/02841860510029590.Acta Oncol. 2005.PMID: 16076694Clinical Trial.
Lee SS, Lee JL, Ryu MH, Chang HM, Kim TW, Kang HJ, Kim WK, Lee JS, Kang YK.Lee SS, et al. Among authors: kang hj, kang yk.Jpn J Clin Oncol. 2007 Jan;37(1):30-7. doi: 10.1093/jjco/hyl134.Jpn J Clin Oncol. 2007.PMID: 17272321
Kim JG, Ryoo BY, Park YH, Kim BS, Kim TY, Im YH, Kang YK.Kim JG, et al. Among authors: kang yk.Cancer Chemother Pharmacol. 2008 Feb;61(2):301-7. doi: 10.1007/s00280-007-0476-x. Epub 2007 Apr 12.Cancer Chemother Pharmacol. 2008.PMID: 17429626
Lee JL, Ryu MH, Chang HM, Kim TW, Yook JH, Oh ST, Kim BS, Kim M, Chun YJ, Lee JS, Kang YK.Lee JL, et al. Among authors: kang yk.Cancer Chemother Pharmacol. 2008 Apr;61(4):631-7. doi: 10.1007/s00280-007-0516-6. Epub 2007 May 23.Cancer Chemother Pharmacol. 2008.PMID: 17520252Clinical Trial.
Park YH, Lee JL, Ryoo BY, Ryu MH, Yang SH, Kim BS, Shin DB, Chang HM, Kim TW, Yuh YJ, Kang YK.Park YH, et al. Among authors: kang yk.Cancer Chemother Pharmacol. 2008 Apr;61(4):623-9. doi: 10.1007/s00280-007-0515-7. Epub 2007 May 24.Cancer Chemother Pharmacol. 2008.PMID: 17522863Clinical Trial.
Lee JL, Kang HJ, Kang YK, Ryu MH, Chang HM, Kim TW, Sohn HJ, Kim H, Lee JS.Lee JL, et al. Among authors: kang hj, kang yk.Cancer Chemother Pharmacol. 2008 Apr;61(5):837-45. doi: 10.1007/s00280-007-0541-5. Epub 2007 Jun 20.Cancer Chemother Pharmacol. 2008.PMID: 17579864Clinical Trial.